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The dystrophin gene, at Xp21, has 79 exons. 2 DMD is caused by deletions in the dystrophin gene in 60%-65% of patients, by duplications in 5%-10%, and by point mutations or small rearrangements in the remaining 20%-30%. The main pathological effects caused by mutations in the dystrophin gene are in the skeletal and cardiac muscles, although dystrophin is present in several other tissues of the body, including a widespread distribution in the nervous system. 5 In addition to full-length dystrophin, four other shorter proteins are transcribed from the DMD gene: Dp260 (transcripts spliced to exon 30), Dp140 (transcripts spliced to exon 44), Dp116 (transcripts spliced to exon 56), and Dp71 (transcripts spliced to exon 63). 6, 7 In the retina, dystrophin is expressed at the level of the outer plexiform layer (Dp260) in the inner limiting membrane (Dp71). [7] [8] [9] [10] [11] [12] Dp260 is also found at the cone pedicle, in the region of the ribbon synapse. 13 Electrophysiological studies showed that Dp260 is essential for the physiology of the retina, since patients with DMD and deletions downstream of exon 30 had serious impairment in both scotopic and photopic responses obtained by full-field electroretinogram (ERG). 6, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The role of Dp71 in the retinal electrophysiology is still unknown. In the work of Claudepierre et al., 8 it was associated with the b-wave Muller cells' contribution to the ERG. Dp427 and Dp140 are also present in mouse retina but do not appear to make an important contribution to the ERG. 25 Previous studies of color vision in patients with DMD or Becker muscular dystrophy (BMD), based on Ishihara and American Optical Hardy-Rand-Rittler (AO H-R-R) tests, found that the proportion of red-green defect in this group 26, 27 was in accordance with the proportion observed for the normal population. However, the Ishihara and AO H-R-R tests are screening tests used to detect severe redgreen deficiency, 28 ,29 but they are not sufficiently sensitive to detect moderate or light impairment. Recent studies have demonstrated an advantage of computerized color vision tests over the semiquantitative tests classically used in the evaluation of color vision, such as the FarnsworthMunsell 100-Hue Test. The advantage is due to several aspects inherent to the programmed presentation of testing trials and to the advances in computerized color reproduction, since (1) rigorous psychophysical methodology is used, (2) changes in the chromatic steps can be varied according to the subject being tested, (3) the resolution of the chromatic steps is sufficiently fine to allow threshold measurement, and (4) online computation of the results is available. A shortcoming of the computerized tests is that they are new and experimental, and most are not commercially available. An exception to this limitation is a test designed by Mollon and Reffin, 30 which is available commercially as the Cambridge Colour Test (CCT).
In the present study, we therefore reexamined color vision in patients with DMD, using this new color vision test, which is much more detailed and has been rated as more sensitive than the traditional tests. [31] [32] [33] [34] [35] Because it is programmed to simultaneously test the three cone-isolation axes, the CCT allows a more refined analysis of the visual pathways involved in chromatic processing-the parvocellular pathway, which mediates red-green color vision, and the koniocellular pathway, which mediates yellow-blue color vision. 31, 32, 34, 35 We also used the Anomaloscope test-a gold standard for the detection of redgreen defect-and, in addition, the Ishihara and AO H-R-R tests, which had been used in the early studies of patients with DMD.
Methods

Subjects
We evaluated 50 patients with DMD ranging in age from 9 to 21 years (mean 14.9 years; SD 4.3) who were referred by the Associação Brasileira de Distrofia Muscular (ABDIM) and had been given diagnoses and been followed up by the Human Genome Research Center of the Institute of Biosciences of the University of São Paulo. This study followed the tenets of the Declaration of Helsinki. Informed consent was obtained from the subjects after the nature of the study was explained.
The diagnosis of DMD was established by clinical and neurological examination, family history, grossly elevated serum creatinine levels, and DNA analysis. It is known that ∼60%-65% of patients with DMD have deletions in the dystrophin gene. Deletion screening used a set of 18 primers that allowed detection of 98% of the deleted exons and that were developed by Chamberlain 36 and Beggs. 37 Motor performance of the patients with DMD was assessed and classified according the Vignos Scale, a scale of motor-function evaluation specific to neuromuscular diseases. 38 The assessment was made by physiotherapists from the ABDIM staff. A total of 50 patients with known deletions in the dystrophin gene were selected for this study. They were classified into two groups according to the deleted region: patients with deletions upstream of exon 30 ( ) and patients with delen p 12 tions downstream of exon 30 (
). This distinction was made n p 38 because retinal dystrophin, Dp260, is known to splice in at exon 30. The demographic data of the 50 patients with DMD are shown in table 1.
An ophthalmological examination was performed for all subjects, to eliminate confounding pathologies, such as cataracts, retinopathy, or neuropathy. Fundoscopy was performed with indirect ophthalmoscopy. Visual acuity was measured at 3 m with use of an ETDRS chart (tumbling E). All patients had normal eye fundus and 20/20 or better best-corrected visual acuity. To constitute the control group, 75 healthy male subjects ranging in age from 9 to 22 years (mean 13.9 years; SD 4.3) were tested. Inclusion criteria for this group were normal eye fundus, 20/20 or better best-corrected visual acuity, and absence of color vision defects.
Five (7%) male subjects did not meet the criteria, since they had congenital color vision defect, and were excluded from the analysis. With these exclusions, the control group was composed of 70 subjects ranging in age from 9 to 22 years (mean 14.6 years; SD 4.9).
Equipment and Procedures
The evaluation of the color discrimination was performed using the commercial version of CCT (v2.0 [Cambridge Research Instruments]) installed in a personal computer (Dell Dimension XTC-600) with a graphic board VSG 2/5 (Cambridge Research Instruments). The stimuli were generated in a high-resolution color monitor, Sony FD Trinitron model GDM-F500T9 (Sony). Testing was conducted in a dark room with the patients positioned 3 m away from the monitor.
The stimulus provided by the CCT was similar to those used in the pseudoisochromatic plate tests, such as the Ishihara test (Kanehara & Co.) or the AO H-R-R (Richmond Products). The target consisted of a Landolt "C" that differed in chromaticity from the single neutral background ( ) randomly distributed in the display. This design used spatial and luminance noise to avoid the influence of cues derived from luminance differences or from target contours in the intended hue discrimination.
The target was randomly presented with its opening in one of four positions: up, bottom, right, and left (4-Alternative Forced Choice strategy). The patient's task was to press one of the four buttons of the response box (CT3 [Cambridge Research Instruments]), to indicate the position of the "C" opening. The patients had up to 15 s to give the response. Patients with motor impairment verbally indicated the gap position, and the examiner pressed the buttons.
A psychophysical staircase procedure was used for threshold determination. Each staircase began with a saturated chromaticity, which was changed along the vector connecting it to the background chromaticity. The change depended on the patient's response: the target chromaticity approached the background chromaticity every time there was a correct response and moved away from it every time there was an incorrect response or no response. The chromaticity excursion along the vectors ranged from 0.1100 to 0.0020 units of CIE 1976 . After six staircase u v reversals, the program automatically calculated the threshold for that vector as the average of the chromaticities corresponding to the reversals. The step size used in the staircase followed a dynamic rule (for more details on the CCT methodology, see the work of Regan et al., 39 and, for CCT norms, see the work of Ventura et al. 32 ). The CCT has two testing procedures. The Trivector test is used to determine thresholds along the protan, deutan, and tritan confusion lines ( fig. 1 ). In this procedure, the three corresponding staircases are conducted simultaneously, in an interleaved way, changing randomly from one to the other. Periodically, a control target at maximum saturation is presented, as a catch trial.
The other CCT procedure is used for the construction of a discrimination ellipse (MacAdam ellipse). In this study, we used NOTE.-N p normal; D p deutan defect; P p protan defect; RG p red-green defect.
eight vectors spaced 45Њ apart to determine the discrimination ellipse around the same background chromaticity that had been used for the Trivector test. The staircases corresponding to these vectors were run in interleaved pairs, randomly chosen by the software. After the detection of the threshold in each vector, the ellipse was traced by interpolation, with use of the minimum squares method. Inside the boundaries of the MacAdam ellipses, color discrimination is lost. This means that, the smaller the ellipse, the better the patient's discrimination ability. The quantitative parameters that are used to describe this ability are the ellipse length, the axis ratio, and the ellipse angle in color space. Ellipse length and angle are indicative of magnitude and type of color defect. We used ellipse area to quantify these changes, as an indicator of the patient's performance in color discrimination.
To confirm the type of red-green defect, the patients were also tested with the type I Neitz Anomaloscope (model OT-II [Neitz Instruments]), a standard test for the detection of red-green color defects. 40 The Neitz Anomaloscope determines the Rayleigh equation for the patient: the mixture of red (670 nm) and green (545 Figure 1 . Left, Image of the stimulus provided by the CCT, showing the spatial and luminance noise (small patches of different diameters and luminances) and the letter "C" formed by the same patches at a chromaticity that differs from the background. Right, CIE chromaticity diagram (1976 u v ) used by the CCT. The gray area indicates all colors seen by the human visual system, and the color triangle exhibits the chromaticities that can be displayed by the video monitor at the luminance level used in the tests. The lines P, D, and T correspond to the protan, deutan, and tritan, respectively, confusion lines tested in the Trivector protocol.
nm) light that matches a reference yellow (589 nm) light. 41 All three lights are produced by filters of equal luminance. The experimental procedure consisted of the observation of a circular horizontally bipartite field with 2Њ of visual angle. The yellow stimulus is in the lower hemifield, which can vary in luminance from dark to bright yellow. The task of the patient is to adjust the color of the upper hemifield to match the color and luminance of that presented at the lower hemifield. This is done by adjusting the proportion of the mixture of the green (545 nm) and red (670 nm) lights, whose combination is projected in the upper field. When both fields are matched in chromaticity, the luminance of the field is about 5 cd#m
Ϫ2
. The proportion used by trichromatic subjects with normal color vision is known from normative studies and was determined here for the control group. The exam was performed in a dark room, in accordance with the procedure recommended by the 1981 National Research Council Committee on Vision. 40 The two pseudoisochromatic color plate tests, used in the genetic studies reported elsewhere, 26, 27 were also used for the evaluation of color vision defects: Ishihara Test for Color Blindness (24 plates edition [Kanehara & Co.]) and AO H-R-R Pseudoisochromatic Plates (AO H-R-R [Richmond Products]). These tests consist of a series of printed plates with spatial and luminance noise forming a multicolored figure, which is also observed against a multicolored background. The only systematic difference between the figure and the background is the color. Patients with normal vision can detect the color differences between figure and the background, whereas patients with color defects fail to do it. The AO H-R-R test was built for the detection, classification, and quantification of red-green and blue-yellow defects. This test is made up of 24 boards in which colored circles of several sizes and luminances form figures in a background of gray circles also of several sizes and luminances. These figures are a cross, a circle, and a triangle. In the Ishihara test, there are numbers instead of figures. The patients were asked to read the numbers in 6 s. This response time was a slight adaptation made after consideration of the characteristics of the study group. The Ishihara test detects only protan and deutan defects and enables a more precise differentiation between both kinds of defects.
Response Reliability
The CCT software incorporates a reliability-testing procedure with catch trials, which present a saturated color at the maximum of the cathode ray tube gamut. These catch trials are presented at different times in the test session and constitute ∼10% of the stimuli. For the Trivector, one color was used in the catch trial (CIE 1976 units). These saturated colors are discriminated even by patients with severe color vision impairment. This procedure tests the ability of the subject to respond correctly to the target, which depends on the understanding of instructions and on the attention directed to the task during the testing session. We define the percentage of correct responses to these catch trials as a measure of reliability. Reliability was 100% for both control subjects and patients with DMD-that is, there were no mistakes in the catch trials. This means that the subjects were performing the required task correctly during the entire length of the testing session.
Statistical Analysis
Statistical analysis was performed with the software Statistica (StatSoft v.6). Statistical differences among the groups were verified with the x 2 test, the Mann-Whitney U test, and the KruskalWallis analysis of variance (ANOVA) by ranks. We use the Tukey honest significance difference (HSD) design for unequal N, to determine the significant differences between group means in the ANOVA setting. The Wilcoxon test was used to assess differences in the Ishihara and AO H-R-R categorical color vision classification. The Spearman rank test correlation was used to verify the relationship between color vision results and the other variables-age and Vignos score. A cluster analysis was performed by measuring a Euclidian distance in a complete linkage rule, to verify similarities and dissimilarities among parameters of the color vision tests, Vignos score, and gene deletion. Adhesion to the normal distribution was checked with the Kolmogorov-Smirnov test. For the CCT Trivector axes, we calculated the tritan/ protan (T/P) and tritan/deutan (T/D) ratios. For the controls, the tritan thresholds are always higher compared with the thresholds of the protan and deutan thresholds, because of distortions of the CIE color space. Alterations in these ratios compared with those of the controls might be used as an indication of color vision anomaly, even if each of the color discrimination thresholds are within the normal tolerance limits. Furthermore, alterations in these ratios are indicative of the type of anomaly. No alteration occurs if the anomaly is diffuse-that is, if there is a uniform change in thresholds. Other patterns reveal specific losses.
For controls, the mean value of the T/P ratio was 1.68 (SD 0.36), and that of the T/D ratio was 1.69 (SD 0.40). For the patients with DMD, the T/P and T/D ratios of the patients with normal thresholds in all Trivector axes, with consideration of the tolerance limits calculated for the control group, were considered. The mean T/P ratio was 1.40 (SD 0.40), and the mean T/D ratio was 1.43 (SD 0.44) for patients with DMD. A statistically significant difference was found between controls and patients with DMD for the T/P (Mann-Whitney U test: , ) and U p 998.90 P ! .003 for T/D ( , ) ratios. This reduction of U p 1,003.90 P p .005 the T/P and T/D ratios indicates a red-green defect, since it results from the fact that the mean thresholds for the protan and deutan axes were elevated relative to the mean tritan threshold.
A red-green color defect was found in 47% (21/44) of the patients with DMD in the CCT. These results were confirmed by the Rayleigh equation, obtained with the Neitz Anomaloscope. A x 2 test showed that there was no difference between the classifications of the color vision defect based on the CCT and on the Anomaloscope ( , ). Diffuse defects were found in 3/44 2 x p 0.680 P p .495 (7%) patients. The Ishihara and AO H-R-R color vision tests detected color vision alterations in fewer patients: the AO H-R-R was able to identify only 3 of 44 (7%), and the Ishihara 2 of 44 (5%), of red-green color vision losses in patients with DMD. In all these cases, a red-green color defect was also detected by the CCT.
A categorical comparison (Wilcoxon test) of color defects obtained with the Ishihara and with the CCT shows that the two tests differ in the ability to detect color defects ( , ). The same comparison between W p Ϫ26.000 P p .026 the AO H-R-R test and the CCT also shows that the results of the two tests differ even more significantly (W p Ϫ , ). The same analysis was made to compare 95.000 P ! .001 the Ishihara and the AO H-R-R color vision classification with the Neitz Anomaloscope. It showed that these two tests have a lower sensitivity to detect red-green color defects than the Anomaloscope (Ishihara, , W p Ϫ20.000 ; AO H-R-R, , ). P p .021 W p Ϫ94.000 P p .009 Color vision thresholds of the control subjects decreased with increasing age, from 9 to 21 years, confirming an improvement in discrimination capacity during this age period, as shown in the literature. 42 This improvement was also observed in the patients with DMD. Spearman rank order correlations between color thresholds and age were negative and statistically significant for the three CCT Trivector thresholds and for the ellipses area (table 2) .
To describe quantitatively the relationship between the color vision result parameters and the genotype variables-region of the gene deletion-we performed a cluster analysis, measuring Euclidian distance in a complete linkage rule. Two clusters were found: one cluster was formed by the area results of the CCT ellipses, and another cluster linked the CCT results with the region of the genetic deletion. In the latter, there are two segregations. The first shows proximity among the region of the gene deleted with the T/P and T/D ratio. The second cluster connects the CCT Trivector results and CCT ellipses angle. Both clusters had an insignificant distance as compared with the CCT ellipses area result.
Since the cluster analysis reveals that there is an association between the CCT color vision results and the region of gene deletion, we analyzed statistical significances considering this parameter. The criterion to separate the DMD patients in groups was based on the ERG studies that showed that exon 30 is essential for normal retina electrophysiology. figure 3B .
Patients with DMD were therefore stratified into two subgroups according to gene deletion: those with deletion downstream of exon 30 ( ) and those with deletion n p 32 upstream of exon 30 (
). There was a high percentage n p 11 (66% [21/32] ) of red-green defects in the patients with deletions downstream of exon 30, whereas color defects were not found in any of the patients with deletions upstream of exon 30, except for a patient with deuteranopia who was previously excluded.
Statistical The improvement of color discrimination with age was confirmed for both subgroups of patients with DMD with gene deletion upstream and downstream of exon 30. The Spearman rank-order correlation data showed reduction in CCT Trivector thresholds and ellipses area as ages increased (see table 2 ).
Discussion
Here we report, for the first time to our knowledge, that red-green color vision defect is highly prevalent in patients with DMD with deletions downstream of exon 30. Since all but one (11/12) of the patients with deletions upstream of exon 30 had normal color vision, the present study suggests that the color defect is related to possible functional damage associated with Dp260, the dystrophin isoform located in the outer plexiform layer. 6, [14] [15] [16] [17] [18] [19] [20] 22 Previous studies on evaluation of visual functions in patients with DMD reported normal ophthalmologic conditions as well as visual functions, including visual acuity, ocular motility, and color vision. 19, 27, 44 However, various degrees of retinal impairment had been found in electrophysiological evaluations. The full-field ERG of patients with DMD showed alterations in scotopic and photopic responses. 6, 15, 16, 18, 19, [22] [23] [24] [25] 43, [45] [46] [47] [48] [49] [50] Indications of impairment in the visual pathways were also observed using visual evoked potential (VEP) techniques. Benoff et al. 47 investigated the contrast sensitivity mediated by magno-and parvocellular pathways isolating the responses of the "ON" and "OFF" subsystems of the visual pathway. They found impairment in the contrast sensitivity mediated by the magnocellular-ON pathway in patients with DMD. In a multimodal evoked potential assessment, Girlanda et al. 50 found reductions for the VEP of patients with DMD and BMD, but not for other modalities, including somatosensory and auditory evoked potentials.
The lack of agreement between the functional evaluations of vision and the electrophysiological studies reported above might be due to the use of procedures that were not sufficiently sensitive to detect functional impairment. We therefore decided to assess visual function with sensitive instruments and focused the present study on color vision.
With the instruments used, we were able to demonstrate that color vision impairment in patients with DMD is highly prevalent. Not only was the incidence of color vision defect very high, but it was also selective and was confirmed by two independent and very different tests. The CCT-a quantitative and sensitive test-showed that patients with DMD had a red-green defect, and this result was confirmed by the gold standard used to measure redgreen color defect, the Neitz Anomaloscope. The incidence of color vision defect among the patients with DMD was 54% (24/44); of these 24 patients, 21 had losses of the red-green type, whereas only 3, or 7%, had diffuse color vision loss. This is a much higher proportion than expected for congenital protan and deutan defects, which occur in ∼7%-10% of the male population. 40, 51 The mechanisms underlying this color vision loss are not known. Patients with DMD present selective impairment in a function mediated by a specific neural pathway-the parvocellular pathway, which mediates redgreen color vision. This pathway is initiated by the response of the L and M cones and comprises a neural network from the retina to the lateral geniculate nucleus and, from there, to several cortical levels. The magnocellular pathway, which mediates achromatic functions, is also initiated by inputs from the L and M cones. 52 In the magnocellular pathway, the signals from the L and M cones are added to convey the information of luminance, whereas, in the parvocellular pathway, the M and L signals are compared, and the neural response expresses their difference, to convey the chromatic information. Chromatic processing includes, in addition, the blue-yellow pathway in which the S-cone signals are compared with the added inputs of the L and M cones. The mean area of the CCT ellipses for controls and for the patients with DMD stratified into two groups: those with deletion downstream or upstream of exon 30. The area of color discrimination ellipses quantify the ability of the subject to discriminate color in all directions around a point in the chromaticity diagram. The smaller the area, the better the discrimination. The downstream group shows statistically significant wider ellipses areas or reduction in color discrimination, compared with the other two groups.
Our findings differ from the result of the work of Benoff et al., 47 who showed that there was magnocellular but not parvocellular impairment in the VEPs of patients with DMD. This disagreement could be due to two factors: (1) The magnocellular pathway is tuned to detect luminance stimuli as the checkboard stimuli that varied in the size of the elements and in the contrast level used in that study. Although the parvocellular pathway also exhibits a response to luminance stimuli, the chromatic stimuli, either red or green, produces the most vigorous activation. (2) The magnocellular pathway collects the response of many more cones than the parvocellular pathway. Since the VEP is a cortical mass response of small amplitude, differences could be more evident in responses mediated by the magnocellular rather than parvocellular pathway.
In the patients with DMD, we found losses mainly in the red-green pathway. These losses may originate in the photoreceptors, since it has been demonstrated by Ueda et al. 12, 13 that dystrophin is located within the invagination of the presynaptic photoreceptor terminal. These invaginated synapses are composed of two lateral processes from horizontal cells and one central process from the ON-bipolar cell, which constitutes a synaptic triad contributing to build the ON visual pathway. If the color defect originates in the photoreceptors, there should be a reduction in all three pathways. In addition to the parvocellular pathway, which mediates red-green color vision, both the magnocellular and koniocellular functions should be affected, since L and M cones constitute inputs in these pathways as well as in the parvocellular pathway. The VEP magnocellular-ON impairment 47 and the ERG ON-pathway impairment 6, 15 found in patients with DMD provide functional evidence in favor of this hypothesis.
The vertebrate visual system has a functional separation of neural pathways that signal ON and OFF responses to light. The ON cells signal in response to illumination, and the OFF cells signal when light is turned off. These pathways are organized in a concentric center-surround antagonism: an excitatory center and an inhibitory surround or vice-versa. 54 The main reason for the presence of ON and OFF channels in the visual system could be to optimize information about increments and decrements of light to the CNS. The same arrangement occurs in the processing of chromatic stimuli, in which ON and OFF signals are generated in response to opponent colors.
Accordingly, the red-green color pathway in the retina has its bipolar and ganglion cells arranged in two types of receptive fields with center-surround spatial antagonism of the L and M cones: L-ON versus M-OFF, and L-OFF versus M-ON. 53, [55] [56] [57] Since the previous literature shows selective impairment of the ON pathway, it is possible that the color vision defect that we report could be reflecting the impairment of only the ON-pathway.
The understanding of the S-cone color processing in the retina is limited, and the existence of the S-OFF cone pathway in the retina is not established. 53, 58 The study by Calkins 59 shows that the ON bipolar cells make contact with S cones in two different ways: there are the characteristic ON-type invaginating contacts and, in addition, other numerous semi-invaginating contacts with the S cones. Since dystrophin would affect the invaginating contacts because of its location near the synaptic ribbon, it might not influence the physiology of these ON bipolars, because most of their contacts with the S cone are located close to but not directly in the invaginating region. This could explain why the patients with DMD had normal tritan thresholds.
The present finding of an association between DMD and red-green color defect in ∼47% of the affected patients constitutes a new finding in the area of DMD studies. The only study that evaluated color vision of the patients with DMD is that of Sigesmund et al., 27 who conducted a complete ophthalmologic evaluation including biomicroscopy, cycloplegic refraction, fundoscopy, prism and cover test, ERG, and tests of color vision, stereoacuity, and visual acuity in 21 patients with a diagnosis of DMD and 5 patients with BMD. Color vision was evaluated in 17 of 21 patients with the use of AO H-R-R, the Ishihara Color Plates, or the Farnsworth D-15 tests. All patients tested had normal color vision, except for one with a severe redgreen defect. This patient had a deletion downstream of exon 30. Since most patients had normal color vision, extraocular muscle function, stereoacuity, and visual acuity, the authors 27 concluded that patients with DMD have normal vision.
The discrepancy between our data showing a high prevalence of red-green color defect in patients with DMD and the study by Sigesmund et al. 27 is probably due to the low sensitivity of the traditional color tests used in that study. Indeed, our results of color vision defect in patients with DMD evaluated with the Ishihara and the AO H-R-R plate tests are in accordance with the results found by these authors 27 and with the expected proportion for congenital color defect in the population. The results obtained here benefitted from a new method for the measurement of color discrimination, developed in the early 1990s, 39 whose norms were provided by Ventura et al. 32 This new procedure has demonstrated a better capacity than the traditional tests to detect color vision defects in retinal pathologies like glaucoma and in hypertension, 35 Parkinson disease, 60 nonretinopathic diabetes, 31 and mercury intoxication, 34 as well as in genetic diseases like dominant optic atrophy 61 and Leber's hereditary optic neuropathy. 62 The psychophysical (staircase) method employed and the four-alternative forced-choice task used by the CCT made possible a precise quantification of the color discrimination threshold. The use of the Neitz Anomaloscope, which is the gold standard to identify and classify red-green color defects, reinforced and confirmed the existence of the selective red-green color discrimination defect in the patients in this study.
The cluster analysis performed on our data revealed a strong association between the color thresholds obtained in the CCT Trivector and the region of gene deletion. Although the full-field ERG shows great variability in patients with DMD, a relationship of these electrophysiological losses with the gene-deletion region was not verified by some authors, 19, 22 whereas other studies were able to show a genotype-phenotype correlation 6, 14, 15, 20, 25 in which the patients with DMD who had the gene deletion downstream of exon 30 had the more preeminent reduction in the ERG b-wave amplitude. The latter studies, therefore, strongly suggested that the dystrophin isoform Dp260 is required for normal retinal function. Our color vision results are in line with those electrophysiological results, since the cluster amalgamation shows that color thresholds have a high level of aggregation with the region of the gene deletion.
The apparent relationship between the region of gene deletion and color vision defects in patients with DMD can be seen in figure 5 . This figure shows the region of gene deletion in each patient, stratifying them into two subgroups according to their red-green color vision results: those with impaired color vision ( fig. 5A ) and those with normal color vision ( fig. 5B ). Red-green color defect was present in 47% (21/44) of patients with deletion downstream of exon 30.
Anomaloscope results from some patients with DMD that indicated a discrete anomalous trichromacy were not in agreement with the CCT Trivector thresholds, which were within the normal limits in the CCT for those patients. However, their T/P and T/D ratios were lower (∼1.0) than those of normal subjects (∼1.7). These threshold ra-tios might offer an index to be checked before considering patients' vision as normal or color defective.
An interesting question is how do these color vision losses impact the daily life of the patient? We would call these subclinical symptoms, since they are not materialized into complaints. Subjects learn to live with less-thanperfect, or defective, color vision. Even individuals with extreme dichromatism often do not find out about their disadvantage until they are adults. A person who has never been faced with another reality has difficulties realizing that she or he is missing information from the world, unless confronted with specific tasks that reveal the loss. This is the basis and motivation of color vision testingto create situations in which the chromatic discrimination can be isolated. Interestingly, our previous experience in color vision testing in several other pathologies [31] [32] [33] [34] [63] [64] [65] showed that very few patients verbalize or are aware of their difficulty to discriminate color or that they have a deficiency.
The improvement of color discrimination with age observed in controls reflects the normal development of this function that reaches its maximum around age 18 years. 42 The patients with DMD also showed improvement in color discrimination measured by the CCT. This finding could be interpreted as evidence that the color defect is nonprogressive in patients with DMD.
Possible cognitive and motor function influences in the assessment of visual function were minimized in our results, since the CCT and Neitz Anomaloscope tasks are cognitively simple and, in the CCT, button-pressing responses were not required for patients with severe motor impairment. We excluded the six patients who had difficulty understanding the CCT instructions. Response reliability was measured in the remaining 44 patients by the assessment of correct responses to a control stimulus that showed a saturated color. There were no errors, showing that these patients were paying attention to the stimulus and were capable of making the discrimination required in the test.
In conclusion, with the battery of tests that we used, not only was it possible to identify the existence of losses in color discrimination, but we were also able to show that these losses were selective for the red-green axis, an observation still not understood.
